Advancing Excellence in Peptide Research
3rd Party Tested in the USA
For laboratory research use only. Not for human consumption, clinical use, diagnostic use, or administration to any living organism.
$109.95
Tesamorelin is a synthetic peptide and analog of growth hormone-releasing hormone (GHRH). It is FDA-approved under the brand name Egrifta to reduce excess deep belly (visceral) fat in adults with HIV-associated lipodystrophy. It works by prompting the pituitary gland to produce natural growth hormone.
Tesamorelin is a synthetic peptide and analog of growth hormone-releasing hormone (GHRH). It is FDA-approved under the brand name Egrifta to reduce excess deep belly (visceral) fat in adults with HIV-associated lipodystrophy. It works by prompting the pituitary gland to produce natural growth hormone.
Compound: Tesamorelin
Format: Lyophilized Powder
Volume: Please see label for specific product details.
Purity Standard: >99%
Product Testing: Independently verified by a 3rd party lab in the USA.
Storage
For optimal stability, refrigerate product at 2–8°C. For long-term storage, freeze at −20°C. Avoid repeated freeze-thaw cycles. Handle in accordance with standard laboratory safety protocols.
Intended Use
Laboratory research only
Returns & Refund Policy
Eligible orders may be returned within 30 days of original purchase date. All orders must remain unopened, unused and in the original packaging with all security seals intact. Approved refunds will be issued to the original payment method within 5–7 business days.
